These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 185806)

  • 1. [Effect of a reduced diet on hyperlipoproteinemia in metabolic-alimentary obesity].
    Frolova IA; Oleneva VA; Zhukova LP
    Vopr Pitan; 1976; (5):39-43. PubMed ID: 185806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
    Jaillard J; Sezille G; Dewailly P; Fruchart JC
    Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
    Jung W; Kremer GJ; Müller D
    MMW Munch Med Wochenschr; 1975 Oct; 117(44):1783-6. PubMed ID: 171564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
    Haacke H; Parwaresch MR; Mäder C
    Med Klin; 1977 Jul; 72(27):1183-7. PubMed ID: 196168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;
    Einarsson K; Hellström K; Kallner M
    J Clin Invest; 1974 Dec; 54(6):1301-11. PubMed ID: 4373491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship of cholesterol (CHO) and triglycerides (TG) in VLDL, LDL, and VLDL subfractions by agarose gel electrophoresis, using CHO and TG dual staining (AG-CHO, TG staining)].
    Miyake N; Iizuka K
    Rinsho Byori; 2002 Jun; 50(6):605-12. PubMed ID: 12166081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Classification and metabolic patterns of hyperlipoproteinemia, with special reference to serum lipoprotein metabolism].
    Kimura N; Nanbu S
    Nihon Rinsho; 1975 Nov; 33(11):3147-56. PubMed ID: 173902
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood lipids and lipoproteins in the age aspect and their role in the development of arteriosclerosis].
    Klimov AN
    Vestn Akad Med Nauk SSSR; 1980; (3):45-9. PubMed ID: 7395328
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P; Schwandt P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contrast-unloading week in the complex therapy of patients with metabolic-alimentary obesity and its effect on changes in body weight and lipid metabolism indices].
    Loĭko VI; Baketova NN; Lebedeva EA; Kolmakov VN; Skovorodnikova ES
    Vopr Pitan; 1979; (5):30-3. PubMed ID: 516598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN; Tvorogova MG; Levitova EN; Krylova EA
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.